Medium for preparing dedifferentiated cells
OwnerLawrence Rosenberg, Stephen Hanley +1inventors
InventorsLawrence Rosenberg, Stephen Hanley, Mark Lipsett
Life of this patent
Estimating the term…
Loading patent…
OwnerLawrence Rosenberg, Stephen Hanley +1inventors
InventorsLawrence Rosenberg, Stephen Hanley, Mark Lipsett
Estimating the term…
The present invention relates to a medium for preparing dedifferentiated cells derived from post-natal islets of Langerhans. The medium comprises in a physiologically acceptable culture medium an effective amount of a solid matrix environment for a three-dimensional culture, a soluble matrix protein, and a first and a second factor for developing, maintaining and expanding the dedifferentiated cells. Such a medium may be used in an in vitro method for islet cell expansion. The present invention also relates to a medium for inducing islet neogenesis from duct-like structure, which comprises in a physiologically acceptable culture medium an effective amount of at least one islet neogenesis inducer compound.
A medium for preparing duct-like structure cells derived from post-natal islets of Langerhans or acinar cells, which comprises in a physiologically acceptable culture medium an effective amount of:
An in vitro method for islet cell expansion, which comprises the steps of:
An in vitro method for producing cells with at least bipotentiality, which comprises the steps of:
A method for the treatment of diabetes mellitus in a patient, which comprises the steps of
A method for the treatment of diabetes mellitus in a patient, which comprises the steps of
A medium for inducing islet neogenesis from duct-like structure, which comprises in a physiologically acceptable culture medium an effective amount of at least one islet neogenesis inducer compound selected from the group consisting of gastrin, hepatocyte growth factor (HGF), epidermal growth factor, transforming growth factor-β1, transforming growth factor-β2, transforming growth factor-β3, insulin-like growth factor-1, insulin-like growth factor-2, insulin, nerve growth factor, keratinocyte growth factor, nicotimanide and insulin-transferrin-sodium selenite.
Dependencies are inferred from the claim text.